Linked Life Data

21511724

Source:http://linkedlifedata.com/resource/pubmed/id/21511724

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
2011-7-6
pubmed:abstractText
Permanent prostate brachytherapy patients are generally told to limit their time around children and pregnant women. However, there is little data available to validate the instruction. For the skin effective dose rate, ion chamber survey meter model 451B-DE-SI was used. The meter was scanned at the point of 4.5, 20, 50 and 100 cm from the skin surface in each plane. Life time exposure was calculated from the average anterior data. At the point of 4.5 cm from the anterior skin surface, the lifetime equivalent dose was 46.5 mSv, at 20 cm it was 13.2 mSv, at 50 cm it was 3.5 mSv and at 100 cm it was 0.9 mSv. The risk from the prostate brachytherapy patients to general public is quite low. Only the case of close and long-time contact with the pregnant and the infant should be paid attention to.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1742-3406
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
146
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
229-30
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Radiation exposure to general public after permanent brachytherapy for prostate cancer.
pubmed:affiliation
Radiological Sciences, Tokyo Metropolitan University, 7-2-10 Higashioku, Arakawa, Tokyo 116-8551, Japan. ykouno@ncc.go.jp
pubmed:publicationType
Journal Article